HomeKNSA • NASDAQ
Kiniksa Pharmaceuticals Internationl PLC
add
$25.95
0.65%
After Hours:(0.00%)0.00
$25.95
Closed: May 22, 4:01:23 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 137.79M | 72.54% |
Operating expense | 62.86M | -3.32% |
Net income | 8.54M | 148.23% |
Net profit margin | 6.20 | 127.97% |
Earnings per share | 0.11 | 144.00% |
EBITDA | 13.62M | 184.70% |
Effective tax rate | 45.14% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 268.34M | 25.66% |
Total assets | 599.33M | 15.33% |
Total liabilities | 141.84M | 61.59% |
Total equity | 457.49M | — |
Shares outstanding | 72.97M | — |
Price to book | 4.16 | — |
Return on assets | 5.62% | — |
Return on capital | 7.25% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 8.54M | 148.23% |
Cash from operations | 22.32M | 459.92% |
Cash from investing | -51.54M | -301.93% |
Cash from financing | 2.77M | -23.39% |
Net change in cash | -26.45M | -179.85% |
Free cash flow | 13.24M | 24.26% |
Previous close
$26.12
Day range
$25.77 - $26.26
Year range
$17.38 - $28.56
Market cap
1.89B USD
Avg Volume
637.03K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2015
Website
Employees
315
